Literature DB >> 14976539

Benign mimickers of prostatic adenocarcinoma.

John R Srigley1.   

Abstract

The diagnosis of prostatic adenocarcinoma, especially when present in small amounts, is often challenging. Before making a diagnosis of carcinoma, it is prudent for the pathologist to consider the various benign patterns and processes that can simulate prostatic adenocarcinoma. A useful method of classifying benign mimickers is in relationship to the major growth patterns depicted in the classical Gleason diagram. The four major patterns are small gland, large gland, fused gland and solid. Most mimickers fit within the small gland category and the most common ones giving rise to false-positive cancer diagnosis are atrophy, post-atrophic hyperplasia, atypical adenomatous hyperplasia and seminal vesicle-type tissue. A number of other histoanatomic structures such as Cowper's gland, verumontanum mucosal glands, mesonephric glands and paraganglionic tissue may be confused with adenocarcinoma. Additionally, metaplastic and hyperplastic processes within the prostate may be confused with adenocarcinoma. Furthermore, inflammatory processes including granulomatous prostatitis, xanthogranulomatous prostatitis and malakoplakia may simulate high-grade adenocarcinoma. Atypical adenomatous hyperplasia (adenosis), a putative precursor of transition zone adenocarcinoma, has overlapping features with low-grade adenocarcinoma and may cause problems in differential diagnosis, especially in the needle biopsy setting. The pathologist's awareness of the vast array of benign mimickers is important in the systematic approach to the diagnosis of prostatic adenocarcinoma. Knowledge of these patterns on routine microscopy coupled with the prudent use of immunohistochemistry will lead to a correct diagnosis and avert a false-positive cancer interpretation.

Entities:  

Mesh:

Year:  2004        PMID: 14976539     DOI: 10.1038/modpathol.3800055

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  30 in total

1.  Quantitative immunohistochemical detection of the molecular expression patterns in proliferative inflammatory atrophy.

Authors:  M Karaivanov; K Todorova; A Kuzmanov; S Hayrabedyan
Journal:  J Mol Histol       Date:  2006-12-15       Impact factor: 2.611

Review 2.  [Differential diagnosis of prostate cancer: impact of pattern analysis and immunohistochemistry].

Authors:  H Bonkhoff
Journal:  Pathologe       Date:  2005-11       Impact factor: 1.011

3.  Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study.

Authors:  Jocelyn Stewart; Neil Fleshner; Heather Cole; Joan Sweet
Journal:  J Clin Pathol       Date:  2006-08-17       Impact factor: 3.411

Review 4.  Diagnosis of adenocarcinoma in prostate needle biopsy tissue.

Authors:  P A Humphrey
Journal:  J Clin Pathol       Date:  2007-01       Impact factor: 3.411

Review 5.  The benign mimickers of prostatic acinar adenocarcinoma.

Authors:  Yuqiao Xu; Yingmei Wang; Ru Zhou; Haiyang Li; Hong Cheng; Zhe Wang; Jing Zhang
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

6.  Periacinar retraction clefting and d2-40 expression in prostatic adenocarcinoma.

Authors:  Monika Ulamec; Tihana Džombeta; Hrvoje Cupić; Tanja Leniček; Davor Tomas; Božo Krušlin
Journal:  Pathol Oncol Res       Date:  2011-09-13       Impact factor: 3.201

7.  Periacinar retraction clefting in proliferative prostatic atrophy and prostatic adenocarcinoma.

Authors:  Monika Ulamec; Davor Tomas; Christian Ensinger; Hrvoje Cupic; Mladen Belicza; Gregor Mikuz; Bozo Kruslin
Journal:  J Clin Pathol       Date:  2007-02-13       Impact factor: 3.411

8.  Investigation of granulomatous prostatitis incidence following intravesical BCG therapy.

Authors:  Mehmet Balasar; Metin Doğan; Abdulkadir Kandemir; Hakan Hakki Taskapu; Faruk Cicekci; Hatice Toy; Recai Gurbuz
Journal:  Int J Clin Exp Med       Date:  2014-06-15

9.  Hematospermia and xanthogranulomatous prostatitis: An unusual onset of a rare diagnosis.

Authors:  Antonio Luigi Pastore; Giovanni Palleschi; Andrea Fuschi; Natale Porta; Bruna Cerbelli; Claudio Di Cristofano; Vincenzo Petrozza; Antonio Carbone
Journal:  Can Urol Assoc J       Date:  2013 Nov-Dec       Impact factor: 1.862

10.  Immunohistochemical expression of prostate tumour overexpressed 1 (PTOV1) in atypical adenomatous hyperplasia (AAH) of the prostate: additional evidence linking (AAH) to adenocarcinoma.

Authors:  Roberta Mazzucchelli; Marina Scarpelli; Francesca Barbisan; Alfredo Santinelli; Antonio Lopez-Beltran; Liang Cheng; Rodolfo Montironi
Journal:  Cell Oncol (Dordr)       Date:  2012-11-07       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.